The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion

Mon, 06th Mar 2023 10:48

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Amur Minerals Corp, up 57% at 1.58 pence, 12-month range 0.6p-3.28p. The natural resources explorer completes the USD35 million disposal of 100% of its interest in AO Kun-Manie, to Bering Minerals. Kun-Manie is a wholly-owned subsidiary of Irosta, which is Amur's wholly-owned subsidiary. Will pay out a special dividend of 1.8p within 90 days of receipt of the sale funds. Back in November, Amur said it faced delays to the sale, due to restrictions on transferring funds to Russia. "We are pleased to have achieved the sale of Kun-Manie which will enable the company to move forward in a new direction, which we envision will result in shareholders seeing real value," says CEO Robin Young.

----------

Plexus Holdings PLC, up 40% at 4p, 12-month range 1.6p-6.2p. The engineering services provider secures an order for its wellhead equipment and sealing technology for a specialised project application. Under the GBP5 million contract, its Pos-Grip HG equipment and technology will be deployed over the next 12 months. About GBP2.5 million will be received via milestone payments in the current financial year ending June 30, with the remainder to be recognised as sales revenue in financial 2024. CEO Been van Bilderbeek says the contract "significantly increases the visibility of [the firm's] future revenue and cash flow projections, and Plexus' reputation as a "can do" surface or subsea equipment solutions provider.

----------

AIM - LOSERS

----------

Fusion Antibodies PLC, down 33% at 32p, 12-month range 30p-110p. The antibody developer says revenue and earnings for the year ending March 31 are expected to be "significantly" behind market expectations, with revenue to be no less than GBP2.8 million. This is due to continuing uncertainty over the timing of several anticipated orders, which is outside the firm's control. As Fusion shifts its focus on larger integrated service contracts, it notes "very positively received" discussions with several potential clients.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
14 Jan 2022 14:15

Fusion Antibodies forms new scientific advisory panel

(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies announced the formation of a new scientific advisory panel (SAP) of experts on Friday, to support research and development across its range of antibody services, and to provide advice regarding emerging science and technology issues and trends.

Read more
6 Dec 2021 14:54

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

Read more
6 Dec 2021 11:59

Revenues rise, losses widen for Fusion Antibodies

(Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.

Read more
2 Dec 2021 22:01

TRADING UPDATES: SRT Marine Systems and ULS Technology losses widen

TRADING UPDATES: SRT Marine Systems and ULS Technology losses widen

Read more
29 Nov 2021 16:08

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
7 Oct 2021 12:11

IN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract

IN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract

Read more
7 Oct 2021 11:59

Fusion Antibodies signs collaborative deal with US biotech firm

(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies has signed a collaborative research and development agreement with an unnamed US-based biotechnology company which was recently incorporated to focus on a number of innovative early-stage antibody programmes, it announced on Thursday.

Read more
24 Sep 2021 11:55

Fusion Antibodies performing in line in year-to-date

(Sharecast News) - Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.

Read more
24 Sep 2021 11:01

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

Read more
17 Sep 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 Aug 2021 12:35

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

Read more
10 Aug 2021 14:01

IN BRIEF: Fusion Antibodies shares fall after annual loss widens

IN BRIEF: Fusion Antibodies shares fall after annual loss widens

Read more
10 Aug 2021 12:44

Revenues rise, losses widen for Fusion Antibodies

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies reported a 7% improvement in full-year revenues in its final results on Tuesday, to £4.2m.

Read more
23 Jul 2021 19:20

TRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down

TRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down

Read more
23 Jul 2021 09:32

Fusion Antibodies receives first research milestone payment

(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies has achieved its first research milestone payment as part of its ongoing collaboration with a major client, it announced on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.